Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism
Publication
, Conference
Carpenter, K; Major, S; Tallman, C; Chen, L; Franz, L; Sun, J; Kurtzberg, J; Song, A; Dawson, G
Published in: NEUROPSYCHOPHARMACOLOGY
November 1, 2017
Duke Scholars
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
November 1, 2017
Volume
42
Start / End Page
S495 / S496
Location
Palm Springs, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP) and Cognitive-Neuroscience-Society
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Carpenter, K., Major, S., Tallman, C., Chen, L., Franz, L., Sun, J., … Dawson, G. (2017). Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism. In NEUROPSYCHOPHARMACOLOGY (Vol. 42, pp. S495–S496). Palm Springs, CA: NATURE PUBLISHING GROUP.
Carpenter, Kimberly, Samantha Major, Catherine Tallman, Lyon Chen, Lauren Franz, Jessica Sun, Joanne Kurtzberg, Allen Song, and Geraldine Dawson. “Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism.” In NEUROPSYCHOPHARMACOLOGY, 42:S495–96. NATURE PUBLISHING GROUP, 2017.
Carpenter K, Major S, Tallman C, Chen L, Franz L, Sun J, et al. Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism. In: NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP; 2017. p. S495–6.
Carpenter, Kimberly, et al. “Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism.” NEUROPSYCHOPHARMACOLOGY, vol. 42, NATURE PUBLISHING GROUP, 2017, pp. S495–96.
Carpenter K, Major S, Tallman C, Chen L, Franz L, Sun J, Kurtzberg J, Song A, Dawson G. Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism. NEUROPSYCHOPHARMACOLOGY. NATURE PUBLISHING GROUP; 2017. p. S495–S496.
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
November 1, 2017
Volume
42
Start / End Page
S495 / S496
Location
Palm Springs, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP) and Cognitive-Neuroscience-Society
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences